Filing metadata

Accession number
0001209191-22-048166
Form type
Form 4
Filer
CRISPR Therapeutics AG
CIK
CIK 1674416
Filed
Aug 31, 2022
Reporting period
Aug 29, 2022
Description
Insider transaction

Explore SEC Filings Hub